Adragos Pharma News and Resources

Adragos Pharma has completed a €4 million investment at its Leipzig, Germany facility, significantly increasing its liquid filling capabilities. The project involved the installation of a cGMP-compliant liquid filling line and a cartoning machine, boosting production capacity nearly tenfold. The newly

Adragos Pharma, a Munich-based global contract development and manufacturing organisation (CDMO), has announced the acquisition of Baccinex, a Swiss provider of aseptic fill-finish manufacturing. The acquisition enhances Adragos’ sterile manufacturing expertise, furthering its global expansion strategy. The financial terms of

Adragos Pharma, a contract development and manufacturing organisation (CDMO), has completed a €13 million ($13.8 million) investment at its Livron-sur-Drôme site in France. The enhancement includes a new ampoule filling line and a state-of-the-art cleanroom, increasing the facility’s output by